コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ta-arrestin-independent Erk1/2 activation by 5-HT4 receptor.
2 ng >5 h in slice recordings, mediated by the 5-HT4 receptor.
3 ng of the physiology and pharmacology of the 5-HT4 receptor.
4 ort-circuit current via submucosal 5-HT3 and 5-HT4 receptors.
5 ed that the effects of 5-HT were mediated by 5-HT4 receptors.
8 region that mediates the effect of enhanced 5-HT4 receptor activity and CK2 as modulator of 5-HT4 re
9 and benzimidazolone series possessed greater 5-HT4 receptor affinity than the corresponding indole an
10 e serotonin (5-HT)2C receptor antagonists, a 5-HT4 receptor agonist, a 5-HT7 receptor antagonist, NMD
11 led to the development of several selective 5-HT4 receptor agonists and antagonists that may have th
16 le-3- carboxamide) as a potent and selective 5-HT4 receptor antagonist with clinically suitable pharm
18 nificantly attenuated by selective 5-HT2 and 5-HT4 receptor antagonists, but not by a 5-HT3 receptor
21 m (SNP) (rs201253747) c.*61 T > C within the 5-HT4 receptor gene HTR4 to be predominantly present in
25 rtantly, it is sufficient to overexpress the 5-HT4 receptor in the mPFC to generate mice with a simil
27 dentifying the role of 5-hydroxytryptamine4 (5-HT4) receptors in the initiation of the peristaltic re
31 T4 receptor activity and CK2 as modulator of 5-HT4 receptor levels in this brain region that regulate
35 ibition, whereas specific 5-HT3 (Y-25130) or 5-HT4 receptor (RS39604) antagonist failed to block the
41 this regulation is region-specific, with the 5-HT4 receptor upregulated in prefrontal cortex (PFC) bu
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。